Insider · CIK 0001826361

GAROFALO ELIZABETH A.

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001826361

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	118,650
2026-06-17	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2026-06-03	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,507
2026-06-03	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+1,593 sh	—	—	1,593
2026-06-01	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,645 sh	—	—	2,645
2026-06-01	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,645 sh	—	—	0
2026-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,107 sh	—	—	33,489
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,107 sh	—	—	0
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,004
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,311 sh	—	—	9,311
2025-09-02	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−1,600 sh	$25.98	−$41.6K	25,382
2025-06-11	ALECAlector, Inc.A Award	Director	AAward	+28.7K sh	—	—	89,950
2025-06-11	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,450 sh	—	—	9,450
2025-06-05	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,012
2025-06-05	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+2,645 sh	—	—	2,645
2025-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+9,387 sh	—	—	26,982
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,387 sh	—	—	0
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,793
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,107 sh	—	—	8,107
2025-03-05	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−4,919 sh	$18.23	−$89.7K	17,595
2024-06-12	ALECAlector, Inc.A Award	Director	AAward	+35K sh	—	—	61,250
2024-06-05	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,542
2024-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,652 sh	—	—	22,514
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,652 sh	—	—	0
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,959
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,387 sh	—	—	9,387
2024-03-08	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,500 sh	$18.56	+$65K	3,500
2024-03-08	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−1,408 sh	$46.16	−$65K	2,092
2024-03-08	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,092 sh	$45.69	−$95.6K	0
2024-03-08	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,500 sh	—	—	16,500
2023-12-05	ALECAlector, Inc.G Gift	Director	GGift	−9,459 sh	—	—	26,250
2023-11-24	ACADACADIA PHARMACEUTICALS INCG Gift	Director	GGift	−2,918 sh	—	—	15,862
2023-06-14	ALECAlector, Inc.A Award	Director	AAward	+26.3K sh	—	—	35,709
2023-06-14	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,360
2023-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,475
2023-06-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,552 sh	—	—	18,780
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,552 sh	—	—	0
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,045
2023-06-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+6,652 sh	—	—	6,652
2022-09-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,919 sh	—	—	10,228
2022-09-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,919 sh	—	—	0
2022-06-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-16	ALECAlector, Inc.A Award	Director	AAward	+9,459 sh	—	—	9,459
2022-06-16	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,918
2022-06-13	XCUREXICURE, INC. · Employee Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-06-07	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+14.4K sh	—	—	14,368
2022-06-07	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,552 sh	—	—	8,552
2022-06-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,391 sh	—	—	8,309
2022-06-07	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,391 sh	—	—	0
2021-09-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,918 sh	—	—	1,918

Recent filings

Accepted (ET)
Jun 174
GAROFALO ELIZABETH A.0001193125-26-274132
SEC(opens sec.gov)
Jun 34
GAROFALO ELIZABETH A.0001193125-26-256122
SEC(opens sec.gov)
Jun 14
GAROFALO ELIZABETH A.0001826361-26-000002
SEC(opens sec.gov)
Sep 34
GAROFALO ELIZABETH A.0001415889-25-023592
SEC(opens sec.gov)
Jun 124
GAROFALO ELIZABETH A.0000950170-25-085618
SEC(opens sec.gov)
Jun 64
GAROFALO ELIZABETH A.0000950170-25-083323
SEC(opens sec.gov)
Jun 24
GAROFALO ELIZABETH A.0001415889-25-015272
SEC(opens sec.gov)
Mar 64
GAROFALO ELIZABETH A.0001415889-25-007299
SEC(opens sec.gov)

Companies

Address

C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600

SOUTH SAN FRANCISCO, CA, 94080